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                                                  INTRODUCTION 
          Junctions  of  two  different  types  of  epithelia  can  give  rise  to  tumors  
which  may show features of either of the colliding epithelia or a mixture or 
intermediate of both. One  such  junction  is  the  ampulla  of  Vater,  the  
luminal  opening  of  common channel formed by the common bile duct and the 
main pancreatic duct of Wirsung within  the  wall  of  the  duodenum.  Here  the  
pancreatic  and  bile  duct  epithelia  meet  the  duodenal  mucosa  at  the  
ampulla(1). 
          Tumors  involving  the  ampulla  could  be  arising  primarily in the 
ampulla or extending  from  the  adjacent  sites  like  duodenum,  bile duct  and  
pancreas. Tumors arising  at  any  of  these  sites  can present as an ampullary/ 
periampullary growth. When  a  neoplasm  is  centered  primarily  in  the 
ampulla with or without periampullary mucosal involvement,  it  is  considered  
a  primary  ampullary   carcinoma (2).  These  tumors  generally  have  a  better  
prognosis  compared  to  duodenal  and  pancreaticobiliary neoplasms  
secondarily  involving  the  ampulla ( 3,4). 
           Primary  ampullary carcinomas arise from the ampulla and present as 
exophytic or ulcerated lesions.  Based on  the microscopic appearance these are 
divided into intestinal,  pancreaticobiliary or  mixed  types( 3,4.) Distinguishing 
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between the two primary types has prognostic implications, as the 
pancreatiobiliary type ampullary carcinomas are said to have a poorer prognosis 
compared to the intestinal type (5,6.) Morphological analysis alone may not 
suffice in this context. The role of immunohistochemistry  has  therefore  been  
explored  by  various  groups of workers. The  cytokeratin  expression pattern- 
CK7 Negative / CK20 Positive in  the  intestinal type  and  CK7 Positive / 
CK20  Negative  in  pancreaticobiliary  phenotype was found to  correlate  with  
morphology  in  some  of  these  studies.(7, 8)  However studies by other  workers  
contradicted  these  observations .(9,10)  The  purpose  of  the  present  study  was  
to  determine  the  role  of  morphology  and  Cytokeratin  profile  in accurate 
typing of ampullary carcinomas as intestinal and pancreaticobiliary. 
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                                     AIMS & OBJECTIVES 
 
 
1. To correlate the morphology of ampullary carcinomas with cytokeratin 
immunoprofile. 
 
2. To determine whether the histopathological & immunohistochemical 
subgroups correlate with clinical, radiological and known prognostic factors. 
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MATERIALS & METHODS 
Seventy  two  cases  of  ampullary  carcinoma  were  received  in  the  
department of pathology,  PSGIMS&R  over  a period of 8 years, from  January 
2003   to October 2011.  Of  these, 25 were pancreaticoduodenectomy 
specimens and 47, endoscopic biopsy  specimens.  After screening  the relevant 
paraffin sections and blocks, thirty cases were selected out of 72, using the 
following criteria. 
1. Histopathological features were unequivocally those of a pure, invasive 
adenocarcinoma. 
2. The neoplasm involved primarily the ampulla of vater, with or without 
periampullary extension, as judged by gross examination of the resection 
specimens and by the endoscopic appearance recorded in the case of small 
biopsies. Those with an exclusively periampullary pattern of growth were not 
included in the study. 
3. Availability of adequate tissue in the paraffin blocks, for further study. 
Hematoxylin and Eosin stained paraffin sections of the selected cases were 
reviewed  and  the  relevant  sections  with  corresponding  blocks  isolated. 
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           A  proforma  including  points  of  patient  identification,  relevant 
clinical date and  details  of  pathological  findings (appendix 1) was prepared 
and filled in. 
           Clinical data included the mode of presentation and endoscopic /per 
operative findings, obtained from case files and pathology request forms. 
Access to case files in the medical records section was obtained through 
permission from concerned authorities. 
          Pathological examination required recording of gross, microscopic and 
immunohistochemical findings. 
          A.GROSS EXAMINATION: 
a. Resection specimens: The specimens available were examined and 
findings recorded. In cases where the specimen had already been discarded, the 
required details were obtained from the gross description in the histopathology 
report. Location and pattern of growth i.e ampullary or mixed ampullary/ 
periampullary , size of the lesion, gross morphology i.e ulcerative, polypoid or 
stenosing, involvement of head of pancreas, duodenal  wall,   common bile  
duct  and  lymph  nodes,  were  recorded   for each of the resection specimens. 
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b. Endoscopic  biopsy  samples:  Whatever  information  regarding  the  
pattern  of  growth,  size  and  gross morphology, that could be obtained from 
the endoscopic observation, were collected from pathology request forms or 
patient files and recorded.   
  A.MICROSCOPIC EXAMINATION: 
          Architecture  of  the neoplasm i.e tubular, papillary, mixed etc, cell 
morphology  including  cell  height  and nuclear atypia and nature of the stroma 
were the salient microscopic features included.  An attempt was made to 
classify each of the tumors as intestinal, pancreaticobiliary or mixed based on 
their appearance in the routine hematoxylin and eosin stained sections. 
B. IMMUNOHISTOCHEMISTRY:  
Immunostaining for CK 7 and CK20 was done on sections from all the 30 
selected blocks using the technique as described below.( 11) 
TECHNIQUE: 
Two cases of  colonic  carcinoma  and one  case of cholangiocarcinoma were  
chosen  as controls for  CK 7 & CK 20 respectively. 4μ thick sections from the 
chosen  paraffin  blocks were made.  They  were  mounted  onto the glass slides 
and were  stained  with  routine  hematoxylin and eosin stain. These slides were 
reassessed for adequacy. Fresh sections from the blocks were cut again at 5μ 
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thickness and taken on to a Poly-L-Lysine coated slide. Same procedure was 
carried out on the control sections too. 
                          Immunohistochemistry for the detection of CK 7 & CK 20 
expression was done using the super sensitive polymer – HRP detection system 
along with appropriate controls.  3, 3’diaminobenzidine tetra hydrochloride 
(DAB) was used as the chromogen. The procedure followed is described below. 
         Method:  The supersensitive polymer – HRP detection system 
         Antibody: CK7 & CK 20 (Biogenex) 
          Principle: Antigens in tissues and cells was detected by a two stage 
process: the binding of  the primary antibody to specific epitopes and the 
subsequent detection of this binding by a colorimetric reaction using a substrate 
chromogen.  
 The method is based on the utility of compact dextran polymer 
to which multiple molecules of the enzyme (Horse radish peroxidase) are 
attached to each linker secondary antibody (specific for the unconjugated 
primary antibody). The primary antibody (CK7 & CK 20) for the antigen to be 
localised is first employed. This is followed by the addition of dextran polymer 
with multiple conjugated secondary antibodies. Multiple secondary antibodies 
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react with different antigenic sites on the primary antibody, thereby increasing 
the signal amplification with the use of a suitable chromogen 3, 
3’diaminobenzidine tetra hydrochloride (DAB). 
 
Primary antibody                                        Secondary antibody 
                                                                                                    
                                                                                                 
                                                                                                   
                                                                                          
              --- Polymerase enzyme 
              --- Secondary antibody 
              --- Primary antibody                             ---- Dextran polymer 
              ---- Tissue antigen          
9 
 
           ANTIGEN  RETRIEVAL: Various methods are used to expose the 
antigenic sites  (epitopes)  that  may  be  unexposed (masked)  during routine 
processing due to formation of cross linking by the action of formalin. The 
methods to unmask the epitopes include digestion with a variety of proteolytic 
enzymes, microwave heating, and lastly exposure to the combined effects of 
heat and pressure in a stainless steel pressure cooker as is said to be more 
uniform. It can recover almost full antigenicity. In this study, antigen retrieval 
was carried out using pressure cooker for 10 min, using Citrate Buffer at a pH 
of 6.0. 
         REAGENTS:  
         1. Citrate buffer at pH of 6.0. It was prepared by dissolving Tri sodium 
citrate (2.94g) in 1000ml of distilled water and 5ml of 1 N Hcl.                        
         2. 3% H2O2 in distilled water to block endogenous peroxidase activity. 
         3. Phosphate buffered saline (PBS) with a molarity of 0.01M and the pH 
value of 7.6. It was prepared by dissolving the following substances in 1000 ml 
of distilled water. 
        Na2HPO4 Dibasic sodium phosphate, anhydrate              17.5g 
        KH2PO4 Monobasic potassium phosphate, anhydrous     2.5g  
10 
 
        NaCl Sodium chloride                                                        17.0g    
4. Blocking reagent- contained casein in PBS with 15mM sodium azide. 
This was used to blocks non specific protein binding. 
5. Primary antibodies against CK 7 & CK 20 mouse monoclonal antibodies 
supplied in liquid form. (Biogenex). 
6. Poly HRP reagent- anti-mouse and anti-rabbit IgG complex linked to 
Horse radish peroxidase enzyme. 
7. DAB (3, 3’Diamino Benzidine tetra hydrochloride) - Chromogen. 
          It offers great sensitivity as an HRP calorimetric chromogen and provides   
insoluble permanent coarse brown precipitate. 
8. Harris hematoxylin as counter stain. 
9.  DPX (Distrene dibutyl phthalate Xylene) - Mountant. 
          PROCEDURE:   
1. Sections were cut at 4μ thickness and taken on a egg albumin coated    
slide. 
2. Routine Hematoxylin and eosin stain was done and reassessed. 
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3. Sections were cut at 5 micron thickness and taken on a Poly-L-Lysine 
coated    slide. 
4.    Immunohistochemical Staining  with CK 7 & CK 20 antigen was done as     
follows: 
        a. Slides were dewaxed and dehydrated in graded alcohol. 
        b. Heat  induced  antigen  retrieval  in  citrate buffer at pH 6.0 using 
pressure      cooker  for 10 minutes  
        c. Washed in PBS buffer at pH 7.6 for 5 minutes twice 
        d. Slides were immersed in 0.3% H2O2 solution for 20 minutes to block 
endogenous peroxidase activity. 
        e. Washed in PBS buffer thrice, each for 5 minutes 
f.    Slides incubated with blocking solution for 10 minutes to block non-
specific protein binding. 
        g. Washed in PBS buffer thrice. 
h.    Slides were incubated with CK 7 & CK 20 primary antibody for 1 Hr on 
the    respective sections. 
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         i. Enhancer was applied to the sections for 30 minutes to enhance the 
signal intensity. 
         j. Washed in PBS buffer thrice. 
         k. Slides were incubated with polymer Horse radish peroxidase reagent. 
         l. Washed in PBS buffer thrice. 
        m. Diamino Benzidine (DAB) is applied for 7-8 minutes. 
        n. Washed in PBS buffer thrice. 
        o. Sections counter stained with Harris hematoxylin for 1 minute. 
        p. Washed in tap water. 
         q. Sections cleared in Xylene and mounted with DPX mountant.  
          The  sections  were  assessed  using  the light  microscope,  under  low  
power  and  high power objectives. Tumors  cells were scored positive if there 
was brown cytoplasmic staining  or  membranous  accentuation in  the 
neoplastic cells. Scoring is done in the well stained area with no interference by 
nonspecific staining background.  
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  Immunoreactivity was evaluated as follows: 
          The extent of staining was graded from 0-3 based on the percentage of 
cells    expressing the marker as shown below: 
          (0)     No cells expressing the marker. 
          (1)   < 25% of neoplastic cells expressing the marker. 
           (2)     25– 50% of neoplastic cells expressing the marker. 
           (3)   > 50% of neoplastic cells expressing the marker. 
          The intensity of staining was also assessed, though in a subjective manner 
and     graded from 1 + to 3 +. This was done by two individuals independently 
(UA & VN) and the results were compared. 
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REVIEW OF LITERATURE 
          The  word  ampulla  means  a  flask   like  dilatation  of  a  tubular 
structure. The ampulla of  Vater is the confluence of the distal common bile 
duct and the main pancreatic  duct  in the second portion of the duodenum. In 
some individuals, the ampulla is a termination of the common bile duct only, as 
the pancreatic duct enters the duodenum separately next to the ampulla. The 
ampulla measures 1.5cm in length or lesser, traverses the duodenal wall and 
open into the duodenal lumen through the major duodenal  papilla (papilla of  
Vater).  It is approximately 0.5cm in diameter with mucosal  reduplications 
(valves of Santorrini) and is lined by pancreatobiliary type ductal epithelium 
with occasional Goblet cells. There is a subtle transition to the intestinal type of 
epithelium at the duodenal surface of the ampulla. Endocrine and paneth  cells  
are  scattered  in  the  non  intestinal ampullary mucosa. The lamina propria has 
occasional lymphocytes, plasma cells and mast cells.( 1,3,12,13). 
          The  lymphatics  drain  into  the  anterior and posterior 
pancreaticoduodenal lymph nodes and to the superior and inferior lymph nodes 
at the head of the pancreas.  
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          Ampullary  carcinomas  constitute 5% of  gastrointestinal carcinomas 
seen in people aged  more  than  60 years usually. Clinical symptoms and signs 
include jaundice, itching, loss  of  appetite,  loss  of  weight,  pale  colored 
stools and others signs of biliary obstruction(14). 
         Ampullary  carcinomas  though  usually  small at the time of diagnosis 
present with early obstructive symptoms thereby resulting in early detection. 
Most of these tumors present  as  a  small  mass  projecting into the duodenal 
lumen or as periductal thickening or bulging of the papilla. Intrampullary 
tumors extending into duodenal mucosa can present as an exophytic or 
ulcerative growth.( 12,15) 
          Spread  of  these  tumors  may  be  invasive  or noninvasive. Noninvasive 
spread includes spread intramucosally to the duodenum as well as to the 
proximal areas of common bile duct and pancreatic duct. The invasive tumors 
spread through the musculature  into  the  adjacent  duodenal and/or pancreas. 
The lymph nodes involved are the peripancreatic group. Distant metastasis is 
usually to the liver, also the peritoneum, lungs and pleura. Vascular and 
perineural invasion are also known to occur in these tumors.(16,17 ) 
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         Pathologic staging is difficult due to the complexity of the anatomy of the 
ampulla of Vater. Ampullary  carcinomas  have  been  staged  by  the AJCC  
Cancer staging manual 6th edition.( 12) 
          Based  on   the  primary  tumor(T) , there  are seven stages such as Tx  
wherein   the  tumor  cannot  be assessed, T0 when there is no evidence of the 
primary tumor, Tis for carcinoma in situ, T1 when  the tumor  is limited to 
ampulla of Vater, T2 when the tumor invades duodenal wall, T3 when the 
tumor invades pancreas and T4 when the tumor invades peripancreatic soft 
tissues or other adjacent organs or structures. 
          The  problem   with  this  staging  is that most invasive carcinomas 
located at the ampulla  of  Vater  would have invaded the duodenal mucosa by 
default. So it  is difficult to designate a  tumor  as  belonging  to stage T1 or T2 
based on this criterion. Also , there  are  rare pancreatic  acinar  lobules in  the 
wall of  the ampulla and therefore invasion of  these acini is not considered T3.  
          Based  on  the   regional  lymph  node  involvement,  there are three 
stages, Nx when  the  regional lymph nodes cannot be assessed, N0 when there 
are no regional lymph node metastasis and N1 with regional lymph node 
metastasis. 
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          Based on distant metastasis there are three stages such as Mx when 
distant metastasis cannot be assessed, M0 when there are no distant metastasis 
and M1 when there is distant metastasis.  
          Pancreaticoduodenectomy is the treatment of choice and the mainstay of 
therapy. (3,4,18) 
          The ampullary carcinomas are different from those arising elsewhere in 
the small intestine  in  that  the  ampullary epithelium  shows  features of both 
duodenal epithelium  and  the associated ducts. Accordingly ampullary 
carcinomas are divided into  intestinal  and  pancreaticobiliary  types. Mixed  
tumors  are composed of both types of epithelium. Other less common or rare 
types are mucinous, signet ring cell, papillary, hepatoid, clear cell, 
adenosquamous, squamous and medullary carcinomas.(12)  
         The mucinous adenocarcinomas are the third in frequency of ampullary 
carcinomas. They are characterized by abundant extracellular mucin and are 
also referred to as colloid carcinomas.  
          Signet ring cell adenocarcinomas show a  diffuse  pattern  of individual 
cells or sheet like or cord like infiltration into the stroma.  
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         Invasive papillary carcinomas may mimic in situ neoplasia because of its 
exophytic growth, formation  of  papillae , branching  architecture  and  
relatively smooth  contours. The stroma is more desmoplastic in this type. 
         The  poorly  differentiated  adenocarcinomas  are  made  up  of poorly 
differentiated cells growing in sheets. 
          The  medullary  carcinomas  have  pushing  borders and show a syncitial 
growth. Lymphoplasmacytic  infiltration  of  the  stroma  is  also a feature. They 
are characterized by microsatellite instability and an association with colonic 
adenocarcinoma. An exceedingly small percentage is constituted by 
neuroendocrine carcinomas. They occur at a relatively higher proportion in the 
ampulla. Sarcomatoid carcinomas are very rare. 
          Intestinal  types  of  ampullary  carcinomas consist  of  elongated, tubular  
units  lined  by  tall  columnar  to  cuboidal  cells  with  oval  nuclei  located in 
the more basal aspects  of  the  cytoplasm   and  often contain mucin.  
Pseudostratification of nuclei, solid  nests and cribriform areas are also features 
described in this subtype. The neoplasm bears a resemblance to intestinal 
carcinomas.(19,20). 
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          The  pancreatobiliary  carcinomas  have  simple  or  branching  glands  
lined  by cuboidal to low columnar epithelium in a single layer. They do not 
exhibit nuclear pseudostratification  and  the nuclei are rounded with marked 
pleomorphism. There often is a marked desmoplastic reaction in the stroma in 
these tumors.(4,5,11,21) The intestinal type  carcinomas  have a better prognosis 
when compared to pancreaticobiliary type .(3,4,22,23) 
 
 MORPHOLOGY AND IMMUNOHISTOCHEMISTRY CORRELATION 
          Previous  studies  have  indicated that immunostaining for cytokeratins 
may help characterize intestinal and pancreatobiliary type of ampullary 
carcinoma, due to differential  expression of cytokeratins, especially CK 7 & 
CK 20. Cytokeratins  are proteins  of keratin-containing intermediate filaments 
found in the intracytoplasmic  cytoskeleton of epithelial tissue.(24)  Normal  
hepatobiliary  and  pancreatic  epithelium express  cytokeratin7,  the  small  
intestinal  mucosa  expresses  cytokeratin 7and Cytokeratin 20 and  the  colonic  
epithelium  is  predominantly  cytokeratin 20  positive. (25,26)  Gastric  mucosa  
has  CK7  and  CK 20  variably  expressed in different parts  & mucosal 
types.(27)  However ,  it  has  also  been  observed that  the tumors arising  in 
these locations need not necessarily translate the normal CK pattern.(10)  
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          Jennie et al studied the expression of cytokeratins 7 and 20 in carcinomas 
of the extrahepatic  biliary  tract,   pancreas  and  gall  bladder.  53 carcinomas 
were included in  the  study,  of  which  8  were  of  extrahepatic  biliary  duct,  
7 ampullary carcinomas, 11  carcinomas  of  the gall  bladder  and 27 
carcinomas of the pancreas. The  study  showed  that  most  tumors  of  the  
pancreas  and  bile  duct  were  CK 7 +ve/ CK 20 –ve  tumors.  This  same  
pattern  of  CK 7/20  expresion was also seen  in  carcinomas  of  the  ampulla,  
pancreas  and  majority  of  gall  bladder  and  bile duct carcinomas. The results 
failed to support usefulness of CK immunohistochemistry  in  differentiating 
pancreatobiliary from intestinal type ampullary carcinoma.(10) 
          Jong  Sun Choi et al also studied the expression of cytokeratins 7 and 20 
in periampullary  carcinomas.  61 resected  specimens  were included in the 
study, of which 20 were pancreatic duct adenocarcinomas, 13 distal bile duct 
carcinomas, 10 duodenal  adenocarcinomas  and 18 ampulla of Vater 
adenocarcinomas.  > 5% tumor cells taking  up  diffuse  staining  was  
considered  positive  reactivity. The pancreatic ductal  adenocarcinomas  and  
the distal  bile  duct adenocarcinomas  were  CK 7 +ve/ CK 20 –ve. The  
duodenal  adenocarcinomas  and  carcinomas of the ampulla were either  CK7 
+ve/ CK 20 +ve or CK7 +ve/ CK 20 –ve. There was a tendency for increased 
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CK 20 positivity in less differentiated carcinomas of the ampulla of Vater. It 
was suggested that CK 7/ CK 20 immunophenotype especially CK 20 
expression correlated to some extent with the site of origin of periampullary 
carcinomas and tumor grade.(28)  
          Cytokeratins 7, 20 and 17 reactivity  were  studied  in  pancreatic  and  
ampulla  of  Vater  adenocarcinomas  by  Goldstein and Bassi. 64 
pancreaticobiliary adenocarcinomas  were  included  in  their  study. The 
adenocarcinomas were divided into  3  groups  based  on  the  tissue   which  
was  infiltrated  by  the tumor. There groups were ampulla only, pancreas only 
and ampulla and pancreas. Immunohistochemical staining for cytokeratins 7, 20 
and 17 was performed on these groups.  The intensity  of  the  stained  cells  
were quantified as weak reactivity, moderate reactivity and strong reactivity. In 
the ampulla only group, cytokeratins 7 was strongly reactive in all and 
cytokeratin 20 was positive in 43% of the cases. In the ampulla  and  pancreas  
group,  strong  Cytokeratin 7  reactivity  was  observed  in  91% of the tumors . 
23% adenocarcinomas had strong cytokeratin20 reactivity. CK7 +ve/ CK20 –ve 
pattern was the most common which constituted 55% to 75% of the neoplasms.  
Though  CK 20  expression  was  more among the ampullary group, the study  
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could  not  confirm  a  useful  role  for CK profile in the subtyping of these 
tumors.(9) 
          Zhou  et  al were  the  first  to show agreement between the histological 
classification and immunohistochemical characterization based on cytokeratins. 
A comparative histologic/ immunohistochemical classification and follow up of 
carcinoma of ampulla of  Vater  was  done  by  these  authors.. The histologic 
classification was done according  to  the  histologic  criteria  published  by 
Albores-Saavedra et al29. They found  24  pancreatobiliary,  15  intestinal  and  
16  other  types  of  carcinomas  in a total of 55 cases. They found a high 
specificity for CK7 for pancreatobiliary type carcinomas  and  CK20  for   
intestinal  type  carcinomas.   Most  of the tumors correlated by histology and 
immunohistochemistry. 21 of 24 (87.5%) carcinomas of histologically  
pancreatobiliary  type  were  of  immunohistochemically  CK7+ve / CK20-ve. 9 
of 15 (60%) intestinal type carcinomas showed the intestinal CK 
pattern(CK20). 16 carcinomas which were classified as the ‘other’ type were 
immunohistochemically  divided into 8 pancreatobiliary and 4 intestinal type 
carcinomas.  4 remained as ‘other’. The  histologic classification  correlated 
well with the immunohistochemical classification in these tumors.(30)  
23 
 
         The  expression  of  cytokeratins  7  and  20  in  ampullary  carcinomas 
was studied by Le Pessot et al with an attempt to correlate the immunostaining 
profile in those tumors. 54  cases of adenocarcinomas were studied 
retrospectively. The details included were the  macroscopic  and  histological  
details  and  immunostaining for cytokeratin 7 and 20.  In  their  study,  26%  of  
the  tumors  were  intestinal, 65% were pancreatobiliary and  9%  were  of the 
mixed type. There was a strong correlation between the histological subtype 
and the CK7/CK20 immunostaining profile.(8) 
          Cytokeratin  7  &  20  expression  were  studied  for  differentiating  the  
tumor  subtypes by  Roh YH  et al. According to these authors, performing 
immunohistochemical staining was helpful to differentiate between the two 
types of ampullary carcinomas.(31) 
          In an attempt to understand the accuracy with which 
immunohistochemical markers differentiate between pancreatobiliary and 
intestinal type adenocarcinomas in the pancreatic head, Westgaard et al did a 
study on 114 resected adenocarcinomas of pancreatobiliary and intestinal types, 
of which 67 were pancreatobiliary and 47 intestinal. The histopathological 
features of these tumors were recorded and immunostaining for CK 7 and CK20  
was performed. 78% of the tumors morphologically correlated well with 
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CK7/20 pattern. 58 pancreatobiliary & 30 intestinal tumors were correctly 
identified by IHC evaluation indicating a moderate agreement between 
morphology and immunohistochemistry.(32)  
 MORPHOLOGY-MUCIN TYPE CORRELATION 
 Mucins are a family of high molecular weight, heavily glycosylated proteins 
(glycoconjugates)  produced by epithelial tissues . Different types of mucins are 
produced  in  different  parts  of  the  gastrointestinal  tract,  biliary  tract and 
pancreas. At  the  ampulla  exists  a  combination  of  sulphated  acid  mucins  
from pancreatic duct,  sialomucins from common bile duct and duodenal 
mucosa and neutral mucins from Brunner’s glands.(33)   Mucins have been 
subtyped based on the structure of the core protein into MUC1, MUC2 etc. It 
has been found that Mucin 1 is expressed in the pancreatobiliary  
adenocarcinomas  and  Mucin 2  in  the  intestinal  type.(34,35) Monoclonal 
antibodies have been developed to these phenotypes. Attempts have been made 
to correlate ampullary carcinoma subtypes with mucin immunohistochemistry. 
           Kawabata  et  al  conducted  a  study  on  surgically  resected  specimens 
from 43 patients  with  ampullary  carcinoma. The tumors were classified based 
on morphology as intestinal and pancreatobiliary type carcinomas. Tumors with 
mixed morphology were grouped under intestinal or pancreatobiliary based on 
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the predominant morphological component. CK 20 and mucin1 expression was 
studied on these tumors. They found that CK20 had high sensitivity for 
intestinal type carcinoma (100%) and MUC1 had high sensitivity (94%) for 
pancreatobiliary type carcinoma.(34) Sessa et al studied 53 resected ampullary 
adenocarcinomas and analyzed them for  MUC1, MUC5 AC, MUC 6, MUC2 
using immunohistochemical techniques. The expression of MUC1 and MUC5 
AC appeared to be peculiar features of pancreatobiliary adenocarcinoma and a 
strong production of MUC2 was associated with an intestinal histology.(33) 
           Other studies have also shown that MUC 2 expression is seen in 
intestinal type adenocarcinomas and that MUC 1 is associated with 
pancreatobiliary adenocarcinomas.(34,35)  
 
TUMOR TYPE-SPREAD/PROGNOSIS STUDIES 
          The  clinicopathological  findings in the two histologic types of 
carcinoma of the ampulla of  Vater was investigated by Kimura et al.(6)  They 
classified ampullary carcinomas into two types; the intestinal type that 
resembles the tubular adenocarcinomas of the stomach or colon and the 
pancreatobiliary type which is characterized  by  papillary  projections  with  
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scant  fibrous  cores. They did this study on  53 resected specimens  of  
carcinomas  of  the ampulla of Vater. The pancreatobiliary and intestinal 
histologic types were found in 38 & 13 cases respectively. Both types of 
epithelia was found in 11 cases, but they were classified according to the 
predominant histologic type that was present. Undifferentiated carcinoma was 
found in 2 cases. They also found that the incidence of lymph node metastasis  
was  higher  in  cases  of  pancreatobiliary  type  than  in the intestinal type and  
that  histological  infiltration  of  pancreatic  parenchyma  was  also more 
frequent in the pancreatobiliary type thereby denoting a worse prognosis for this 
type of ampullary carcinoma.  
           Howe et al in their series had 70% of the ampullary cancers with an 
intestinal morphology which showed a trend toward improved survival as 
against the pancreatobiliary  histologic subtypes ( median survival of  59.6 
versus 22.5 months)(5). 
           In the  study by Le Pessot  et  al, follow up details of the ampullary 
carcinomas were documented in addition to the morphology and 
immunohistochemical staining profile. The five year survival rate was 100% for 
the intestinal subtype and 40% for the pancreatobiliary  type ampullary 
carcinomas. According to this study, the immunohistochemical staining and 
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morphological subtype correlated well and that the intestinal subtype had a 
favorable prognosis.(8) 
          Roh et al in their series of 34 patients with ampullary carcinoma found 
that long term survival  post  resection  was  significantly  greater  in  intestinal  
type  tumors  as against the pancreatobiliary type. These authors had also found 
statistically effective correlation between morphological subtype and CK7/ 
CK20 expression.(30) 
         In  a  study of 157 patients with ampullary carcinoma correlating tumor 
histology and survival  Jonathan  et  al  found  that  lymphovascular invasion, 
perineural invasion, stage and pancreatobiliary subtype predicted survival. 
Pancreatobiliary type of ampullary carcinoma had worse survival.(9) 
          In  the  study  by Westgaard(19), histological type of  differentiation, 
tumor origin, pT stage, maximum tumor diameter, resection status, nodal 
involvement, perineural infiltration, vascular involvement and degree of 
differentiation were the factors taken into  account  for  the  histopathological  
assessment  of  the  resected  specimens.  All the tumors were assigned to one 
of the two histological types. The pancreatobiliary tumors were associated with 
resection margin involvement, perineural involvement, areas  with  poor  
differentiation, lymph node involvement, vessel involvement and tumor size 
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greater than 25mm and had a poor prognosis . They concluded that histological 
type significantly discriminates between prognostically poor pancreatobiliary 
and prognostically good intestinal types of pancreatic head adenocarcinomas. 
          Georgescu et al  explored  the  relevance  of  histopathological  typing  of  
periampullary tumors  for  survival  in 38 patients. They assessed not only the 
Histopathological  features  but  also  tumor stage , size, degree of 
differentiation  and  lymph node involvement. 60.5% of cases were intestinal 
and 39.5% of the cases were pancreatobiliary in type. The median overall 
survival was found to be significantly higher in patients with well differentiated 
intestinal type in T1-T2 stage without lymph node involvement. These authors 
concluded that intestinal type of periampullary carcinoma has a longer survival 
but lymph node involvement and degree  of differentiation remained significant 
prognostic factors associated with high mortality(36).  
          Kawabata et al in addition to establishing correlation between tumor 
morphology, CK20 expression and MUC1 expression , also observed a better 
prognosis in intestinal type ampullary  carcinoma  based  on  pT  stage and node 
metastasis. These authors found that intestinal type carcinoma is slow to 
progress and carries a lower risk of nodal metastasis when compared to the 
pancreatobiliary and other unusual histological subtypes(34). 
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         The  above  mentioned  studies have been based on correlation between 
the  histomorphologic  tumor  type  and  prognosis. Very few studies have been 
based on molecular characteristics of these carcinomas.  One such study is done 
by Gheza F et al (37). They studied the differential gene expression between 
pancreatoduodenal  adenocarcinomas  and  ampullary  carcinomas.  Among  the  
different genes expressed, it  was found that Hepatocyte nuclear factor 4 alpha 
(HNF4α) was over expressed in ampullary carcinomas(7.61 fold greater)  
compared  to  pancreatoduodenal  adenocarcinoma. It was also seen that 
HNF4α expression correlated with its histological  subtype,  grading ,  CDX 2  
positivity, MUC1 negativity , which are all  features  of  ampullary  carcinomas. 
Multivariate  analysis  also  revealed  that HNF4α  negativity  and  lymph node  
positivity are independent negative predictors of  survival.  Thereby  HNF 4α 
protein expression is an independent predictor of favorable prognosis in 
carcinomas of the ampulla of Vater.  
          Sudo T et al (38) attempted to identify the prognostic factors in patients 
undergoing pancreatoduodenectomy with lymphadenectomy for ampullary 
carcinoma. The  records of 46 patients with ampullary carcinoma who underwent 
pancreatoduodenectomy were reviewed. Their overall survival rate was 64%. 
Univariate analysis revealed that tumor stage, lymph node metastasis and 
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perineural invasion were significant predictors of poor prognosis. No attempt was 
made to correlate tumor type with prognosis.  
In a review of 36 patients with ampullary carcinoma  who underwent 
pancreatoduodenectomy, Yamaguchi et al (39) , studied the prognostic factors. 
They pointed  out  that  pre operative serum Carcinoembryonic antigen levels, 
lymphatic permeation, perineural invasion were significant parameters influencing 
survival post-surgery. Of these , histologic invasion of the venous space was 
found to be  an independent prognostic factor .  
A  study  was  done  on  the  pathological factors influencing survival of 
carcinoma of the  ampulla of Vater by Mori et al(40). 24 patients post 
pancreatoduodenectomy were examined pathohistologically  and the prognostic 
factors  were evaluated. Five year survival at stage 1 was 100%, stage 2 was 
64.2% and stage 3 was 15%. Only one patient with stage 4 survived for more than 
5 years. Localization  within the ampulla and lymph node metastasis were 
significant prognostic  indicators. Other factors like shape of the tumor, invasion 
into veins and  lymphatic vessels in the primary lesion and type of local invasion 
were also indicative of influencing survival. Tumor size, histological type and 
stromal reaction in the primary lesion did not correlate with survival.  
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Iacono et al (41) attempted  to  evaluate the prognostic significance of different 
clinico-pathological  and  molecular factors, and to compare survival after 
standard and extended pancreaticoduodenectomy  in ampulla of Vater 
adenocarcinoma. They have studied 5-10 year survival in 59 patients who 
underwent pancreatoduodenectomy for ampulla of Vater  adenocarcinoma. 
Surgery  alone proved to be curative in patients with only microsatellite 
instability. But it was inadequate  in patients showing chromosome 17p allelic 
loss. It was suggested that these patients might benefit from adjuvant therapy.  
Prognostic  molecular  factors in ampullary adenocarcinoma could be of 
significant importance, thus necessitating the need to identify these factors. The 
possible prognostic significance of cyclooxygenase-2 (COX-2) after surgical 
resection  was  thereby  studied  by Santini.D et al (42). COX-2 is a rate limiting 
enzyme which is involved in the conversion of arachidonic acid to H2 
prostoglandin. COX 1 and COX 2 gene have been identified, of which COX 1 is 
constitutively  expressed  in  many  tissues  and is involved in many functions 
such as cytoprotection of the stomach, vasodilation in the kidney and the 
production  of  thromboxane  by  the  platelets. COX 2 which  has been shown to 
be involved in carcinogenesis is induced by inflammation or by mitogens, 
cytokines and growth factors. COX 2 over expression is found in various 
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histologic types of pancreatic carcinomas and so inhibition of COX 2 could be 
effective in countering  the development of human pancreatic carcinomas. This 
study examines the possible prognostic significance of COX 2 expression in 
radically resected ampullary  cancer patients. These authors for the first time in 
the literature , have reported  a statistically  significant  association between high 
COX 2 expression   and poor  clinical outcome and can be considered an 
independent prognostic  indicator  in  ampullary carcinomas. The mechanisms by 
which over expression of COX 2 is associated with poor prognosis of carcinoma 
of  the ampulla  of  Vater  have  not  been  elucidated.  COX 2  expression  has  
been linked  to  tumor  invasion,  thereby  proving  to  be  a poor prognostic factor 
for patients with  cancer of the ampulla of  Vater. 
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RESULTS 
Twenty one out of the thirty cases studied showed correlation between 
morphology and CK7/CK20 staining pattern. Of these two were intestinal in 
type, fourteen were pancreaticobiliary type carcinomas and five showed a mixed 
intestinal pancreaticobiliary morphology as well as immunoprofile (table 1). 
MORPHOLOGICAL TYPE IMMUNE PROFILE NO. OF CASES 
Intestinal (I) CK7(-)/CK20(+) 2 
Pancreaticobiliary (PB) CK7(+)/CK20(-) 14 
Mixed CK7(+)/CK20(+) 5 
TOTAL 21 
 
Table 1: Morphological and Immunohistochemical 
correlation in the subtypes of ampullary carcinoma. 
 
The remaining nine cases showed immunoprofile at variance with morphology. 
Thus, three cases interpreted as ‘intestinal’ on morphological grounds turned out 
to be CK7 positive /CK20 Negative (PB type cytokeratin profile) and two were 
CK7 positive /CK20 positive (“ mixed”) cytokeratin profile, another three cases 
with pancreaticobiliary morphology were CK7 positive /CK20 positive             
(“ mixed”), CK7 negative /CK20 positive (I) and CK7 negative /CK20 negative 
34 
 
(unclassified), respectively. One case had mixed morphological features but 
showed cytokeratin profile confirming to pancreaticobiliary type carcinoma 
(CK7 positive /CK20 negative) (table 2). 
MORPHOLOGY CYTOKERATIN PROFILE NO. OF CASES 
Intestinal CK7+ / CK20- (PB) 3 
Intestinal CK7+ / CK20+ (M) 2 
Pancreaticobiliary  CK7+ / CK20+ (M) 1 
Pancreaticobiliary  CK7+ / CK20- (I) 1 
Pancreaticobiliary  CK7- / CK20- (-) 1 
Mixed CK7+ / CK20- (PB) 1 
                                                                         TOTAL 9 
 
Table 2: shows the nine cases lacking morphology 
immunohistochemical correlation 
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AGE AND SEX: 
The age of the patient in the present study ranged from 38 to 74 yrs, the overall 
average being 56yrs. The average age for intestinal type carcinoma was 58yrs, 
for pancreaticobiliary type 57yrs and for the mixed type 56yrs. 
Of the twenty one cases with morphological and immunohistochemical 
correlation, sixteen were men and five women. No difference in the incidence of 
tumor subtypes between the sexes was observed, pancreaticobiliary type being 
the comment in both (M-12/16 and W- 4/5). 
 
CLINICAL PRESENTATION: 
All the patients presented with obstructive jaundice. Some complained of loss of 
weight and abdominal pain and a few presented with recurrent pancreatitis. 
 
RADIOLOGICAL FINDINGS AND TUMOR TYPE: 
Radiological findings were obtained from the hospital records in ten cases. Of 
these only six had correlation between morphology and cytokeratin pattern. All 
but one (5 cases) showed dilatation of biliary duct system. One case showed a 
mass lesion. All the five cases with dilated ducts on radiological examination 
were of pancreaticobiliary subtype and the one case recorded as “mass lesion” 
was of mixed type. 
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ENDOSCOPIC FINDINGS AND TUMOR TYPE: 
Endoscopic findings were available in nineteen cases, of which sixteen had 
morphological-cytokeratin correlation. The lesions had been described as 
ulcer/ulceroproliferative growth (3 cases), mass /polyp/ampullary prominence 
(12 cases) and stricture (1 case). 
8/10 of the pancreaticobiliary subtype presented as mass lesion/ampullary 
prominence and one each as ulcer and stricture. Mixed tumors were five in 
number, of which two were ulcerative and three were mass lesions. The sole 
intestinal subtype in this group of sixteen also presented as mass lesions. In short 
there was considerably overlap in the endoscopic findings among the three 
subtypes (Bar diagram-1). 
 
Bar diagram 1: Distribution of the three subtypes among 
ulcer/ mass lesion/ strictures. 
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LYMPH NODE METASTASIS AND TUMOR TYPES 
A total of fifteen Whipple's resection specimens were included in the study, of 
which nine showed metastatic deposits in the lymph nodes( Pie diagram 1). Of 
these, only seven had morphology correlating with cytokeratin profile, enabling 
the tumors to be subtyped. 
  
Pie chart 1- Lymph node metastasis in 9/15 Whipple’s 
specimens. 
Four out of seven cases with lymph node metastasis were of pancreaticobiliary 
type and three were mixed carcinomas. Pure intestinal carcinomas did not show 
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lymph node involvement . The numbers of this subtype however was too small 
(2/15) to arrive at any definite conclusion. 
 
 
Pie chart 2- Distribution of pancreatobiliary & mixed 
subtypes among 7 tumors  with  metastasis which had 
morphology-IHC correlation 
 
39 
 
The two cases with no morphological immunohistochemical correlation, which 
also showed tumor in lymph nodes, were of pancreaticobiliary (morphology 
intestinal) and mixed (morphological pancreaticobiliary) by cytokeratin profile . 
Of the six cases without lymph node metastasis, three had morphological and 
immunohistochemical correlation. There was one each of intestinal, 
pancreaticobiliary and mixed subtypes in these three. Of the remaining three, 
two were mixed and one was intestinal by immunoprofile. 
 
Regardless of morphological subtypes, it was observed that 9/9 
tumors(100%) with lymph node metastasis expressed CK7 while only 4 out of 
these 9 expressed CK20 (44%).( Bar diagram 2). 
 
 Of the six cases without metastasis 5(83%) expressed CK20 while only 4 
(67%) expressed CK 7  
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Bar diagram 2: CK 7 & CK 20 expression in ampullary 
carcinomas with lymph node metastasis. 
 
 
PATHOLOGICAL FINDINGS: 
GROSS MORPHOLOGY: 
Fifteen of the thirty selected cases were resection specimens. Eleven of 
these fell within the twenty one cases with histomorphological 
immunohistochemical correlation. 
Tumor size ranged from 0.8x0.5cm to 5.0x3.0cm in the entire group of  
fifteen resection specimens. Among the eleven lesions mentioned above six 
measured <2.0cm in the greatest dimension, four measured between 2.0cm and 
4.0cm and one >4.0cm across. 
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Of the six tumors that were < 2.0cm across four were of pancreaticobiliary 
type (4/6-66%). Of the five tumors measuring > 2.0cm across, three were of 
mixed or intestinal type (3/5 60%) (Bar diagram 3) . Smaller tumors were 
predominantly pancreatobiliary, while the larger ones were predominantly mixed 
and intestinal. 
 
 
Bar diagram 3: Correlation between tumor size and subtype. 
 
 
HISTOLOGICAL FEATURES AND CYTOKERATIN PROFILE 
Morphological analysis of the hematoxylin and eosin stained sections 
included assessment of architecture, cell height, nuclear grade and stromal 
desmoplasia. Based on these features all the thirty neoplasms had been 
tentatively grouped as pancreaticobiliary (PB), mixed (M) and intestinal (I) 
types.  Now an attempt was made to correlate each of these histological features 
with CK7 and / or CK20 expression (pie charts 3&4). 
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ARCHITECTURE: 
The main architectural patterns observed were tubular (T), tubular and 
papillary (TP)  and cribriform with solid areas(C.S) in some. Twenty six out of 
the thirty (26/30) cases expressed CK7. Seven out of these twenty six expressed 
a tubular pattern (figure 1), eleven of twenty six expresed T-TP pattern and eight 
of twenty six had C.S pattern. 
Eleven out of the thirty cases expressed CK20 (11/30). All the eleven had 
tubular- papillary (figure 6), cribriform or solid architecture (100%). None 
showed an exclusively tubular pattern. 
ARCHITECTURE CK7/CK20   NO   TOTAL NO 
 
Tubular  
CK7(+)/CK20(-) 7  
8 CK7(-)/CK20(-) 1 
 
Tubular-papillary 
CK7(+)/CK20(-) 8  
14 CK7(+)/CK20(+) 3 
CK7(-)/CK20(+) 3 
 
Cribriform- solid 
CK7(+)/CK20(+)  5  
8 CK7(+)/CK20(-) 3 
                                                                     TOTAL    30 
 
Table 3:  Tumor architecture and CK profile. 
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Pure tubular pattern is seen only in CK7positive and CK 20 negative tumors. 
CK20 positive tumors  show either mixed tubular-papillary or cribriform- solid 
architecture. 
 
CELL HEIGHT AND CK EXPRESSION 
Twelve of the neoplasms assessed consisted of cuboidal and /or low 
columnar cells. Eleven of these showed CK7 +/CK20 - immunoprofile and one 
was CK7 -/ CK20-. 
Eighteen tumors had tall columnar cells either exclusively or in 
combination with cuboidal/low columnar cells types (figures 11&12). Seven of 
these were CK7 (+)/CK20 (-), eight were CK20 (+)/ CK7 (+) (figures 13&14) 
and three were CK7 (-)/ CK 20 (+) (figures 9&10). 
While CK7 expression showed no significant correlation with cell height all the 
eleven CK20+ cases had a considerable proportion of tall columnar cells. 
 
NUCLEAR GRADE AND CYTOKERATIN PROFILE.  
Ten out of  ten cases with +++  nuclear grade(figure 2)  show CK7+ expression. 
Nine of eleven cases with CK20 expression are of low to medium nuclear grade 
(figure 7).  
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    CK PROFILE 
                       
                      NUCLEAR GRADE 
+ ++ +++ 
CK7(+)/20(-) 4 6 8 
CK7(-)/20(-) 0 1 0 
CK7(+)/20(+) 1 5 2 
CK7(-)/20(+) 2 1 0 
 
              TOTAL-  20 TOTAL 10 
 
Table4: Nuclear grade and CK profile. 
 
. 
DESMOPLASIA AND CYTOKERATIN PROFILE. 
CK7 expression was present in 11/12(92%) tumors with 2 to 3+ desmoplasia 
(figures 3&4) (92%) and CK 20, in 5/12 (42%) (figure 5). 
In tumors with 0-1+ desmoplasia (figure 8), 83% expressed CK7 (15/18) and 
33%, CK20 (6/18) (figure 9). 
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CYTOKERATIN 
PROFILE 
DESMOPLASIA 
+ ++ +++ -  
CK7(+)/20(-) 7 5 2 4  
CK7(-)/20(-) 1 0 0 0  
CK7(+)/20(+) 3 3 1 1  
CK7(-)/20(+) 1 1 0 1  
TOTAL 12 9 3 6 30 
 
Table 5: Desmoplasia and cytokeratin profile 
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SUMMARY OF HISTOLOGICAL FEATURES AND CYTOKERATIN 
EXPRESSION 
42%
58%
19%
42%
39%19%
38%
31%
12%
27%
42%
31%
CK 7+ 26/30
CUBOIDAL-
LOW …
100%
27%
55%
18%18%
36%
36%
9%
55%
45%
CK20+ 11/30
 
 
PIE Charts 3 & 4 
 FIGURE 1. PANCREATOBILIARY  TYPE CARCINOMA WITH TUBULAR PATTERN(HEMATOXYLIN-EOSIN ,40X) 
 
FIGURE 2. PANCREATOBILIARY  TYPE  CARCINOMA  WITH  MARKED NUCLEAR ATYPIA        
(HEMATOXYLIN-EOSIN ,400X) 
 FIGURE 3. PANCREATOBILIARY  TYPE  CARCINOMA  WITH DESMOPLASIA(HEMATOXYLIN-EOSIN ,100X) 
 
 
 FIGURE 4. PANCREATOBILIAY TYPE CARCINOMA WITH CK 7 POSITIVITY 
(IMMUNOHISTOCHEMISTRY,400X) 
 
FIGURE 5. PANCREATOBILIARY TYPE CARCINOMA WITH CK 20 NEGATIVITY 
(IMMUNOHISTOCHEMISTRY,100X) 
 FIGURE 6. INTESTINAL TYPE CARCINOMA WITH TUBULOPAPILLARY PATTERN 
(HEMATOXYLIN-EOSIN, 100X) 
 
FIGURE 7. INTESTINAL TYPE CARCINOMA WITH MINIMAL NUCLEAR ATYPIA(HEMATOXYLIN-EOSIN ,400X) 
 FIGURE 8. INTESTINAL TYPE CARCINOMA WITH ABSENCE OF DESMOPLASIA(HEMATOXYLIN-EOSIN ,400X) 
 
 
 
 
 FIGURE 9. INTESTINAL TYPE CARCINOMA WITH CK 20 POSITIVITY(IMMUNOHISTOCHEMISTRY,100X) 
 
FIGURE 10. INTESTINAL TYPE CARCINOMA WITH CK 7 NEGATIVITY(IMMUNOHISTOCHEMISTRY,100X) 
 
 
  
FIGURE 11. TALL COLUMNAR CELLS IN MIXED TYPE CARCINOMA(HEMATOXYLIN-EOSIN ,400X) 
 
 
FIGURE 12. CUBOIDAL CELLS IN MIXED TYPE CARCINOMA(HEMATOXYLIN-EOSIN,400X) 
  
 
FIGURE 13. CK 7POSITIVITY IN MIXED TYPE CARCINOMA (IMMUNOHISTOCHEMISTRY,100X) 
 
FIGURE 14. CK20 POSITIVITY IN MIXED TYPE CARCINOMA(IMMUNOHISTOCHEMISTRY,400X)  
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DISCUSSION 
Carcinomas  of  the  Ampulla of  Vater may arise in the ampulloduodenal part 
lined  by  intestinal  mucosa  or  in  the  deeper part lined  by  pancreatic or bile 
duct mucosa. Intestinal  and  Pancreatobiliary  represent  the  main  histological 
types  of  ampullary  carcinoma.  Morphologically  the  two  types  resemble  their 
colonic and pancreatic counterparts (43). Moreover intestinal type ampullary 
carcinomas  often  possess  immunohistochemical  marker  profile  similar  to  that 
of  colonic  carcinomas  and  the  pancreatobiliary type ampullary carcinomas 
show an immunoprofile resembling pancreatic carcinomas (44). Immunomarkers 
most  useful  in  this context  are  cytokeratin 20, cytokeratin 7 and Mucin 2. Thus 
the  intestinal type tumors express “CK 20+, CK7-, MUC 2+” marker profile, 
while  pancreatobiliary type carcinomas express “CK 7+, CK 20-, MUC 2-“ 
profile.  
               The  present  study is an attempt to correlate the morphology of 
ampullary adenocarcinomas with their immunoprofile. The markers used were 
CK7 and CK 20, both simple cytokeratins with restricted tissue and neoplastic 
distribution.  Cytokeratins  are intermediate  filaments found in the epithelial cells 
of  all types and  are therefore  specific  markers  for an epithelial cell lineage. 
They have been classified as types 1 through 20. The cytokeratin expression is 
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frequently organ and tissue specific. The subtypes of cytokeratins expressed 
depend,  in addition  to  the  type  of  epithelium , on the stage of differentiation 
and development(45). Applications of cytokeratin 7 and cytokeratin 20 in 
combination include study of  Barret’s mucosa,and assessment of metastatic 
carcinomas  with unknown primary, in addition  to typing of ampullary 
carcinomas.  
           Cytokeratins 7  and  20 expression could also have a bearing on the 
prognosis of carcinomas  irrespective of  subtype. At least in one series, on 
colorectal  carcinomas ,  cytokeratin 20 expession was found to be more  in low 
grade tumors and cytokeratin 7 expression more in tumors with lymph node 
metastasis (45). Other studies have however contradicted these observations (26).  
              In the present study , 70% of ampullary carcinomas (21/30) showed 
correlation between morphology and CK7/CK20 profile. Some of the previous 
studies have also yielded similar results (7,8). In the series of Zhou et al overall 
correlation  was  present  in 76% of cases and  pancreatobiliary group alone 
showed  a  higher  percentage  of  correlation  between morphology and 
cytokeratin profile. 
             Clinical ,  radiological and endoscopic data showed considerable overlap 
in the present study. Lymph node metastasis was found to be present in 
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pancreatobiliary and mixed subtypes, but not in intestinal type of ampullary 
carcinoma.  However  only  two  cases out of fifteen Whipple’s resection 
specimens were of  intestinal  type  and therefore  no  definite conclusion could  be 
drawn.  But the cytokeratin 7 and cytokeratin 20 expression taken independently 
did  show that 100%  of  metastatic  tumors  were  CK 7  (9/9)  and  only  44% 
(4/9)  were  CK 20+.  Among  the  cases  without  metastasis in our series 83% 
(5/6)  expressed CK 20 and only 63% (4/6) expressed CK 7.  
                This is in agreement with earlier observations of more cytokeratin 7 
expression in colorectal adenocarcinomas with lymph node metastasis i.e 
cytokeratin  expression  rather  than  histological  type  correlated  with  
 metastasis (46). 
                 We have in this study, made an attempt to correlate individual 
histological  features  like  architecture ,  predominant  cell  type,  nuclear grade 
and degree of desmoplasia separately, with CK 7 expression and CK 20 
expression,  also  taken  separately. It was found that tumors with an exclusively 
tubular architecture always expressed CK 7 but not CK 20.  
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                With  regard  to cell height, CK 20 expression was found to have a 
strong  correlation   with  tall  columnar  cells  in  the  sense that all CK 20 + 
tumors had a tall columnar cell component.  
                 Distribution of the different nuclear grades did not differ between 
cytokeratin 7+ and CK 20+ tumors. But , 100 % of high nuclear grade (+++) 
neoplasms  expressed  cytokeratin 7  and  20 %  expressed  cytokeratin 20.  While 
this  would  suggest  a  correlation  between  CK 7  expression  and  high  grade, 
one  has  to  bear  in  mind  that  majority  of  tumors  in  the  present series were 
either pancreatobiliary or mixed in type, and were CK 7+.  
                    Observations  on  desmoplasia  also  followed  a  similar pattern and 
the results should be viewed against the fact that majority of the tumors were 
anyway cytokeratin 7+.  
                   Finally,  the  significance  of  our  findings  can  be  derived  from  the 
fact  that accurate histologic typing of ampullary carcinomas will provide 
predictive  information  influencing  staging  and  planning of operative 
procedures.  It  will  also  provide a solid basis to analyze pathogenetic 
mechanisms  of  these tumors by more advanced methods such as molecular 
studies. Above all it raises the fundamental question whether ampullary 
adenocarcinoma  is  to  be  considered  an  entity  with  its own staging system, or 
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is to be clubbed under other intestinal and pancreatic carcinomas.  The  number  of  
cases  studied  is  small.  The  three  subtypes were not represented  equally.  In  
spite  of  these  drawbacks  the  following  conclusions can  be  drawn  from  the  
present  study.                          
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                                         SUMMARY & CONCLUSIONS 
1) Tumor morphology of ampullary adenocarcinomas correlates to an extent with 
cytokeratin immunoprofile, and morphological- immunohistochemical 
subtyping is possible in 70% of cases. 
2) Frequency of lymph node metastasis is more in CK 7+ tumors as against CK 
20+ tumors. 
3) Among the microscopic features, an exclusively tubular architecture is 
associated with cytokeratin 7 expression.Tall columnar cell component is 
unequivocally related to CK 20 expression.  
4)  It may further be concluded that correlation between some of the individual 
microscopic features  like architecture and cell height with independent 
cytokeratin7 and cytokeratin 20 expression is greater than that between 
intestinal / pancreatobiliary morphological types and combined cytokeratin 7/ 
cytokeratin 20 profile.  
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S.NO BIOPSY 
NUMBER 
AGE/SEX CLINICAL DETAILS RADIOLOGICAL FINDINGS 
1 2414/10 48/F Obstructive jaundice since 6 months CT shows a small enhancing lesion in D2. 
Endoscopy shows bulky ampulla with small 
ulcer. 
2 2041/10 58/F Obstructive jaundice x  3months Endoscopy shows fleshy ampulla 
3 2208/09 44/M Jaundice – 3 weeks Endoscopy shows nodular mass 
4 1134/10 55/F Obstructive jaundice Endoscopy shows prominent ampulla 
5 1937/10 59/F Jaundice- 3 weeks CT shows a periampullary  mass with 
dilated CBD 
 
 
GROSS FINDINGS EXTENT OF SPREAD 
S. No Type of 
specimen 
Pattern of 
growth 
Size Morphology Local Lymph node 
involvement 
1 Whipple’s 
specimen 
Intraampullary 1x1cm Nodular mass Infiltration into pancreas is 
seen. 
1/6 
2 Whipple’s 
specimen 
Intraampullary 0.8x0.5cm Nodular mass Infiltration into wall of 
duodenum and bile duct 
- 
3 Whipple’s 
specimen 
Periampullary 3x1cm Nodular mass Infiltration into wall of 
duodenum, pancreatic duct and 
focally into pancreatic 
parenchyma 
- 
4 Endoscopic 
biopsy 
Intraampullary - - - - 
5 Whipple’s 
specimen 
Periampullary 4x3cm Ulceroproliferative 
growth 
Infiltration into duodenal wall 
and focally into pancreas 
- 
 
 
  
MICROSCOPIC FINDINGS  
Impression 
IMMUNOHISTOCHEMISTRY Inference 
in  
IHC 
Correlation 
Architecture Cell height Nuclear 
atypia 
Stromal 
desmoplasia 
Extent Intensity Extent Intensity 
Tubule, 
trabeculae 
Low 
columnar 
+++ + PB 3 ++ - - PB √ 
Tubules, 
papillae, 
solid pattern 
Tall 
columnar 
+ - PB 3 ++ - - PB √ 
Tubules, 
papillae 
Tall 
columnar 
+ 
to 
+++ 
- Intestinal 3 +++ - - PB × 
Tubules Cuboidal ++ + PB 3 +++ - - PB √ 
Tubules, 
papillae 
Tall 
columnar 
+ + Intestinal - - 3 +++ Intestinal √ 
 
  
 
S.NO BIOPSY 
NUMBER 
AGE/SEX CLINICAL DETAILS RADIOLOGICAL FINDINGS 
6 S1883/07 40/M Jaundice- 1 month Endoscopy showed a friable prominent ampulla 
7 S707/10 72/M Jaundice- 2 weeks 
Known case of tuberculosis 
Endoscopy showed a periampullary growth 
8 S746/10 57/M Recurrent pancreatitis, abdominal pain 
– 6 months 
Endoscopy- large ampullary growth 
9 S810/10 38/M Jaundice- 2 weeks Endoscopy- polypoid, pedunculated mass 
10 S1184/10 74/M Obstructive jaundice, abdominal pain- 
1 month 
USG- mass in the head of pancreas. 
Endoscopy- prominent ampulla 
 
  
GROSS FINDINGS 
EXTENT OF SPREAD 
S. No Type of 
specimen 
Pattern of growth Size Morphology Local Lymph node involvement 
6 Whipple’s 
specimen 
Intra ampullary 2x3cm Friable, nodular mass Infiltration into pancreas 
and duodenal wall 
1/4 
7 Endoscopic 
biopsy 
Periampullary - - - - 
8 Endoscopic 
biopsy 
Ampullary 1.0cm Nodular mass - - 
9 Whipple’s 
specimen 
Periampullary 5x3cm Polypoid 
pedunculated mass 
- 2/8 
10 Whipple’s 
specimen 
Ampullary 1.9x1.5cm Ill-circumscribed 
firm, bulky mass 
Infiltration into duodenal 
wall 
- 
MICROSCOPIC FINDINGS  
Impression 
IMMUNOHISTOCHEMISTRY 
 
Inference 
in 
 IHC 
Correlation 
Architecture Cell height Nuclear 
atypia 
Stromal 
desmoplasia 
Extent Intensity Extent Intensity 
Tubules, 
cords and 
groups 
Low 
columnar 
++ +++ PB 3 +++ - - PB √ 
Tubules, 
papillae, focal 
cribriform 
Low 
columnar to 
tall 
columnar 
+ 
to 
++ 
+ PB 3 +++ - - PB √ 
Tubules, 
papillae 
Tall 
columnar 
++ - Intestinal - - 2 +++ Intestinal √ 
Tubules, 
papillae 
Low 
columnar to 
tall 
columnar 
++ ++ Int/PB 3 +++ 2 ++ Int/PB √ 
Tubules, 
cribriform and 
solid pattern 
Cuboidal  to 
tall 
columnar 
+ 
to 
+++ 
++ Int/PB 3 +++ 3 ++ Int/PB √ 
S.NO BIOPSY 
NUMBER 
AGE/SEX CLINICAL DETAILS RADIOLOGICAL FINDINGS 
11 S1444/10 68/M Loss of weight, jaundice since 1 month Endoscopy- Friable ulcerated ampulla 
12 S188/09 57/M Jaundice, abdominal pain- 1 month Endoscopy- Duodenal ulcer with a mass in the 
ampullary region 
13 S1264/07 52/M Jaundice, loss of weight- 1 month Endoscopy- Ulcer in ampullary region 
14 S2691/08 55/M Abdominal pain and jaundice- 2 weeks CBD showed an area of hard stricture with 
occlusion of lumen 
15 S3074/09 50/M Jaundice, fever, vomiting- 3 months Endoscopy- Ampullary prominence. 
  
GROSS FINDINGS EXTENT OF SPREAD 
S. No Type of 
specimen 
Pattern of 
growth 
Size Morphology Local Lymph node involvement 
11 Endoscopic 
biopsy 
- - - - - 
12 Whipple’s 
specimen 
Periampullary 1.5x1cm Ulcer with raised 
margins 
Infiltration into 
duodenal wall and 
pancreatic 
parenchyma 
3/6 
13 Whipple’s 
specimen 
Periampullary 4x2cm Ulcer with DL Infiltration into 
duodenal wall 
3/5 
14 Whipple’s 
specimen 
Ampullary 1.5cm Edema of ampullary 
mucosa. Stricture 
with occlusion of 
CBD lumen 
Infiltration into wall of 
duodenum, CBD, 
pancreas 
1/5 
15 Whipple’s 
specimen 
Ampullary 1.5cm Nodular projection 
at ampulla 
- 1/1 
MICROSCOPIC FINDINGS  
Impression 
IMMUNOHISTOCHEMISTRY Inference 
in  
IHC 
Correlation 
Architecture Cell height Nuclear 
atypia 
Stromal 
desmoplasia 
Extent Intensity Extent Intensity 
Tubules Low 
columnar 
+++ + PB 3 +++ - - PB √ 
Tubules, 
papillae 
Tall 
columnar 
++ + PB /Int 2 ++ 1 + PB /Int √ 
Tubules, 
sheets and 
cords 
Low 
columnar to 
tall 
columnar 
++ ++ PB /Int 3 ++ 1 + PB /Int √ 
Tubules Cuboidal to 
low 
columnar 
+++ ++ PB 1 + - - PB √ 
Tubules, 
papillae 
Tall 
columnar 
+ ++ Intestinal 3 +++ - - Intestinal × 
 
 
 
 S. NO BIOPSY 
NUMBER 
AGE/ SEX CLINICAL DETAILS RADIOLOGICAL FINDINGS 
16 S4966/09 65/M Obstructive jaundice- 4 months CT- Dilated CBD and pancreatic 
duct 
17 S2724/09 53/M Jaundice, vomiting- 15 days CT- I HBR dilatation mass lesion 
in periampullary  region of CBD 
18 S853/09 47/M Abdominal pain, loss of weight and 
jaundice- 2 months 
USG- Dilated CHD, CBD upto 
terminal end 
19 S1281/08 57/M Obstructive jaundice- 2 months ERCP- Periampullary growth 
20 S4369 66/M Itching loss of appetite and loss of 
weight- 2 months 
Endoscopy – Growth in D2, dilated 
CBD. 
  
GROSS FINDINGS EXTENT OF SPREAD 
S. No Type of specimen Pattern of growth Size Morphology Local Lymph node 
involvement 
16 Endoscopic biopsy Intra ampullary  Ampullary 
prominence 
- - 
17 Endoscopic biopsy Periampullary  - - - 
18 Endoscopic biopsy Periampullary  - - - 
19 Endoscopic biopsy Periampullary  - - - 
20 Whipple’s specimen Periampullary and 
ampullary 
 Ulceroproliferative 
growth 
Involve adjacent 
duodenum pancreatic 
parenchyma and CBD 
5/10 
 MICROSCOPIC FINDINGS  
Impression 
IMMUNOHISTOCHEMISTY  
Inference  
in  
IHC 
 
Correlation 
Architecture Cell 
height 
Nuclear 
atypia 
Stromal CK7 CK20 
Extent Intensity Extent Intensity 
Tubules,  
cribriform 
Low 
columnar 
+++ ++ PB 1 + - - PB √ 
Tubules,  
cribriform 
Tall 
columnar 
++ - Intestinal 1 + 1 + PB/Intestinal x 
Tubules Low 
columnar 
+ + PB 2 ++ - - PB √ 
Tubules,  
cribriform 
Low 
columnar 
+++ + PB 3 +++ - - PB √ 
Papillary 
cribriform 
Tall 
columnar 
+++ + PB 3 +++ 1 + PB/Intestinal x 
 
 
 S. NO BIOPSY 
NUMBER 
AGE/ SEX CLINICAL DETAILS RADIOLOGICAL FINDINGS 
21 S2193/16 60/M Obstructive jaundice- 4 
months 
Endoscopy- ampullary growth 
22 1640/09 60/M Itching, Abdominal pain and 
jaundice- 1 month 
USG- mass in pancreas 
Endoscopy- ampullary prominence 
23 558/07 52/M Obstructive jaundice CT- dilated main pancreatic duct & 
CBD upto ampulla. No mass lesion 
24 4267/09 70/M Obstructive jaundice Endoscopy- friable growth ampullary 
region 
25 4084 51/M Recurrent pancreatitis- 6 
months 
Endoscopy- ulceration in the 
periampullary region 
 
GROSS FINDINGS EXTENT OF SPREAD 
S. No Type of 
specimen 
Pattern of growth Size Morphology Local Lymph node 
involvement 
21 Endoscopic 
biopsy 
Intra ampullary - Ampullary 
prominence 
- - 
22 Endoscopic 
biopsy 
Periampullary - - - - 
23 Endoscopic 
biopsy 
Periampullary - - - - 
24 Endoscopic 
biopsy 
Ampullary - - - - 
25 Whipple’s 
specimen 
Periampullary 3x2cm Ulcered lesion with 
raised borders 
- - 
 MICROSCOPIC FINDINGS  
 
Impression 
IMMUNOHISTOCHEMISTY  
 
Inference 
 
 
Correlation 
Architecture Cell 
height 
Nuclear 
atypia 
Stromal CK7 CK20 
Extent Intensity Extent Intensity 
Tubules,  
papillae 
Low 
columnar 
++ + PB 2 ++ - - PB √ 
Tubules Cuboidal 
to low 
columnar 
++ + PB - - - - Intestinal × 
Tubules, 
papillae 
Tall 
columnar 
+ - Intestinal 1 + - - PB × 
Tubules,  
papillae 
Low 
columnar 
to tall 
columnar 
++ ++ PB 3 +++ - - PB √ 
Tubules, 
cribriform, 
papillae 
Tall 
columnar 
to 
cuboidal 
+ + Intestinal 1 + 2 ++ PB/Intestina
l 
√ 
 
 
S. NO BIOPSY NUMBER AGE/ SEX CLINICAL DETAILS RADIOLOGICAL 
FINDINGS 
26 4675/10 56/M Pancreatitis, cholecystitis – 
1 month 
Dilated IHBR 
27 3826/10 65/M Obstructive jaundice- 1 
month 
Moderately dilated intra and 
extra hepatic biliary channels 
nad pancreatic duct 
28 3995/10 55/M Obstructive jaundice- 2 
weeks 
ERCP- periampullary growth 
29 680/11 55/M Obstructive jaundice Endoscopy- periampullary 
growth 
30 2845/11 50/M Obstructive jaundice Endoscopy- periampullary 
ulceroproliferative growth. 
 
 
GROSS FINDINGS EXTENT OF SPREAD 
S. No Type of 
specimen 
Pattern of growth Size Morphology Local Lymph node 
involvement 
26 Whipple’s 
specimen 
Ampullary 1.8x0.8cm Ampullary 
prominence 
- 2/8 
27 Endoscopic 
biopsy 
Periampullary - - - - 
28 Endoscopic 
biopsy 
Periampullary - Periampullary 
nodular growth 
- - 
29 Whipple’s 
specimen 
Periampullary 4x2.5cm Ulceroproliferative 
growth 
- - 
30 Endoscopic 
biopsy 
Periampullary - Ulceroproliferative 
growth 
- - 
 
MICROSCOPIC FINDINGS  
Impression 
IMMUNOHISTOCHEMISTY  
Inference 
in  
IHC 
 
Correlation 
Architecture Cell height Nuclear 
atypia 
Stromal CK7 CK20 
 
Extent Intensity Extent Intensity 
Tubules Cuboidal to 
low 
columnar 
+++ ++ PB 3 +++ - - PB √ 
Tubules, 
cribriform 
Low 
columnar 
to cuboidal 
(mucinous) 
++ +++ PB 3 +++ - - PB √ 
Tubules, 
papillae 
Cuboidal to 
tall 
columnar 
+ - PB/ 
Intestinal 
3 +++ - - PB × 
Tubules, 
papillae, 
cribriform 
Tall 
columnar 
to cuboidal 
++ +++ PB/ 
Intestinal 
3 in 
papillary 
pattern and 
negative in 
tubules 
+++ 2in 
papilla
ry to 3 
in 
tubule
s 
++ to 
+++ 
PB/ 
Intestinal 
√ 
Papillae, 
tubules 
Tall 
columnar 
++ ++ PB/ 
Intestinal 
- - 3 ++ intestinal × 
 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 
Architecture                               Tubular    - T T T T T T T T T T T T T T T T T T T T P T T T T T T T T T P Papillary  - P  P P  P  P P P   P   P      P  P P   CR P P T Cribriform- CR          CR      CR CR  CR CR     CR      Solid etc  - S             S                  Cell height                                Cuboidal – C    C      C    C        C   C C C C C  Cuboidal –  Low columnar- LC LC     LC LC  LC  LC  LC LC  LC  LC LC  LC LC  LC  LC LC    Tall columnar - T  TC TC  TC  TC TC TC TC  TC TC  TC  TC   TC   TC TC TC   TC TC TC Nuclear grade                               +  + +  +     +     +   +     +  +   +   ++    ++  ++ ++ ++ ++   ++ ++    ++    ++ ++  ++   ++  ++ ++ +++ +++  +++       +++ +++   +++  +++   +++ +++      +++     Desmoplasia                                -  - -     -         -      -     -   + +   + +  +    + +      + + + + +   +     ++ ++         ++ ++   ++ ++ ++ ++        ++  ++ +++  +++  +++      +++                         CK7 (+) / (-) 3+ 3+ 3+ 3+ - 3+ 3+ - 3+ 3+ 3+ 2+ 3+ + 3+ + + 2+ 3+ 3+ 2+ - + 3+ + 3+ 3+ 3+ 3+ - CK20 (+) / (-) - - - - 3+ - - 2+ 2+ 2+ - + + - - - + - - + - - - - 2+ - - - 3+ 3+ 
 
